Preventing heart failure in patients with diabetes

Medical Clinics of North America

Volumn 88, Issue 5, 2004, Pages 1237-1256

  Srikanthan, Preethi ^a   Hsueh, Willa ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Univ C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL STIMULATING AGENT; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FATTY ACID; GLIBENCLAMIDE; GLUCOSE; LEMAKALIM; PINACIDIL; POTASSIUM CHANNEL; PROBUCOL; PROPRANOLOL DERIVATIVE; VERAPAMIL;

AUTONOMIC NEUROPATHY; BLOOD CLOTTING DISORDER; CALCIUM METABOLISM; CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DRUG MECHANISM; ENDOTHELIUM LESION; FATTY ACID METABOLISM; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART FAILURE; HEART MUSCLE CELL; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIA; KIDNEY DISEASE; MYOCARDIAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; RISK FACTOR; SEX DIFFERENCE;

ALBUMINURIA; BLOOD COAGULATION DISORDERS; CARDIOVASCULAR AGENTS; CAUSE OF DEATH; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERINSULINISM; HYPERLIPIDEMIAS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INCIDENCE; INSULIN RESISTANCE; MALE; OBESITY; OXIDATIVE STRESS; PROGNOSIS; RISK FACTORS; SEX CHARACTERISTICS; UNITED STATES; WORLD HEALTH;

EID: 4444222687     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcna.2004.05.004     Document Type: Review

References (46)

1. Bauters C., Lamblin N., McFadden E.P., Van Belle E., Millaire A., De Groote P. Influence of diabetes mellitus on heart failure risk and outcome. Cardiovasc Diabetol. 2:2003;1
2. Narula J. Heart failure: pathogenesis and treatment. 1st edition:2002;ISIS Medical Media
3. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 339:1998;229-234
4. Shindler D.M., Kostis J.B., Yusuf S., Quinones M.A., Pitt B., Stewart D., et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol. 77:1996;1017-1020
5. Zannad F., Briancon S., Juilliere Y., Mertes P.M., Villemot J.P., Alla F., et al. Incidence, clinical and etiologic features, and outcomes of advanced chronic heart failure: the EPICAL study. Epidemiologie de l'Insuffisance Cardiaque Avancee en Lorraine. J Am Coll Cardiol. 33:1999;734-742
6. Kannel W.B., Hjortland M., Castelli W.P. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol. 34:1974;29-34
7. Rubler S., Dlugash J., Yuceoglu Y.Z., Kumral T., Branwood A.W., Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 30:1972;595-602
8. Trost S., LeWinter M. Diabetic cardiomyopathy. 3:2001;481-492
9. Schannwell C.M., Schneppenheim M., Perings S., Plehn G., Strauer B.E. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology. 98:2002;33-39
10. Poirier P., Bogaty P., Garneau C., Marois L., Dumesnil J.G. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 24:2001;5-10
11. Regan T.J., Lyons M.M., Ahmed S.S., Levinson G.E., Oldewurtel H.A., Ahmad M.R., et al. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest. 60:1977;884-899
12. Way K.J., Isshiki K., Suzuma K., Yokota T., Zvagelsky D., Schoen F.J., et al. Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes. 51:2002;2709-2718
13. Daoud S., Schinzel R., Neumann A., Loske C., Fraccarollo D., Diez C., et al. Advanced glycation endproducts: activators of cardiac remodeling in primary fibroblasts from adult rat hearts. Mol Med. 7:2001;543-551
14. Sima A., Popov D., Starodub O., Stancu C., Cristea C., Stern D., et al. Pathobiology of the heart in experimental diabetes: immunolocalization of lipoproteins, immunoglobulin G, and advanced glycation endproducts proteins in diabetic and/or hyperlipidemic hamster. Lab Invest. 77:1997;3-18
15. Spector K.S. Diabetic cardiomyopathy. Clin Cardiol. 21:1998;885-887
16. Scognamiglio R., Casara D., Avogaro A. Myocardial dysfunction and adrenergic innervation in patients with type 1 diabetes mellitus. Diabetes Nutr Metab. 13:2000;346-349
17. Kahn J.K., Zola B., Juni J.E., Vinik A.I. Radionuclide assessment of left ventricular diastolic filling in diabetes mellitus with and without cardiac autonomic neuropathy. J Am Coll Cardiol. 7:1986;1303-1309
18. Monteagudo P.T., Moises V.A., Kohlmann O. Jr., Ribeiro A.B., Lima V.C., Zanella M.T. Influence of autonomic neuropathy upon left ventricular dysfunction in insulin-dependent diabetic patients. Clin Cardiol. 23:2000;371-375
19. Ungar I., Gilbert M., Siegel A., Blain J.M., Bing R.J. Studies on myocardial metabolism IV. Myocardial metabolism in diabetes. Am J Med. 18:1955;385-396
20. Stanley W.C., Lopaschuk G.D., Hall J.L., McCormack J.G. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovasc Res. 33:1997;243-257
21. Reaven G.M., Lithell H., Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med. 334:1996;374-381
22. Zavaroni I., Mazza S., Dall'Aglio E., Gasparini P., Passeri M., Reaven G.M. Prevalence of hyperinsulinaemia in patients with high blood pressure. J Intern Med. 231:1992;235-240
23. Sowers J.R., Frohlich E.D. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Med Clin N Am. 88:2004;63-82
24. Lithell H.O. Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism. Diabetes Care. 14:1991;203-209
25. Singal P.K., Bello-Klein A., Farahmand F., Sandhawalia V. Oxidative stress and functional deficit in diabetic cardiomyopathy. Adv Exp Med Biol. 498:2001;213-220
26. Liang Q., Carlson E.C., Donthi R.V., Kralik P.M., Shen X., Epstein P.N. Overexpression of metallothionein reduces diabetic cardiomyopathy. Diabetes. 51:2002;174-181
27. Liu X., Wang J., Takeda N., Binaglia L., Panagia V., Dhalla N.S. Changes in cardiac protein kinase C activities and isozymes in streptozotocin-induced diabetes. Am J Physiol. 277:1999;E798-E804
28. Abe T., Ohga Y., Tabayashi N., Kobayashi S., Sakata S., Misawa H., et al. Left ventricular diastolic dysfunction in type 2 diabetes mellitus model rats. Am J Physiol Heart Circ Physiol. 282:2002;H138-H148
29. Golfman L., Dixon I.M., Takeda N., Lukas A., Dakshinamurti K., Dhalla N.S. Cardiac sarcolemmal Na(+)-Ca2+ exchange and Na(+)-K+ ATPase activities and gene expression in alloxan-induced diabetes in rats. Mol Cell Biochem. 188:1998;91-101
30. Nakajima T., Iwasawa K., Oonuma H., Imuta H., Hazama H., Asano M., et al. Troglitazone inhibits voltage-dependent calcium currents in guinea pig cardiac myocytes. Circulation. 99:1999;2942-2950
31. Rozanski G.J., Xu Z. A metabolic mechanism for cardiac K+ channel remodelling. Clin Exp Pharmacol Physiol. 29:2002;132-137
32. Pijna I.L., Buchter C. Heart failure in women. Cardiol Rev. 11:2003;337-344
33. Bell D.S. Treatment of heart failure in patients with diabetes: clinical update. Ethn Dis. 12:2002;S1-S18
34. Zhong Y., Reiser P.J., Matlib M.A. Gender differences in myosin heavy chain-beta and phosphorylated phospholamban in diabetic rat hearts. Am J Physiol Heart Circ Physiol. 285:2003;H2688-H2693
35. Anderson E.A., Mark A.L. The vasodilator action of insulin. Implications for the insulin hypothesis of hypertension. Hypertension. 21:1993;136-141
36. Brands M.W., Hildebrandt D.A., Mizelle H.L., Hall J.E. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol. 260:1991;R764-R768
37. Saad M.F., Lillioja S., Nyomba B.L., Castillo C., Ferraro R., De Gregorio M., et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 324:1991;733-739
38. Morales P.A., Mitchell B.D., Valdez R.A., Hazuda H.P., Stern M.P., Haffner S.M. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes. 42:1993;154-161
39. Quinones M.J., Hernandez-Pampaloni M., Schelbert H., Bulnes-Enriquez I., Jimenez X., Hernandez G., et al. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Int Med. 140:2004;700-708
40. Ouvina S.M., La Greca R.D., Zanaro N.L., Palmer L., Sassetti B. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients. Thromb Res. 102:2001;107-114
41. Mbanya J.C., Sobngwi E., Mbanya D.S., Ngu K.B. Left ventricular mass and systolic function in African diabetic patients: association with microalbuminuria. Diabetes Metab. 27:2001;378-382
42. Rosen R., Rump A.F., Rosen P. The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats. Diabetologia. 38:1995;509-517
43. Brown R.A., Petrovski P., Savage A.O., Ren J. Influence of ATP-sensitive K+ channel modulation on the mechanical properties of diabetic myocardium. Endocr Res. 27:2001;269-281
44. Afzal N., Ganguly P.K., Dhalla K.S., Pierce G.N., Singal P.K., Dhalla N.S. Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes. 37:1988;936-942
45. Fein F.S. Diabetic cardiomyopathy. Diabetes Care. 13:1990;1169-1179
46. Kaul N., Siveski-Iliskovic N., Hill M., Khaper N., Seneviratne C., Singal P.K. Probucol treatment reverses antioxidant and functional deficit in diabetic cardiomyopathy. Mol Cell Biochem. 283:1996;160-161. 283-8